H101 Plus TACE for r/m HNSCC

Abroad (travel likely)RecruitingPHASE2

Conditions

Head and Neck Squamous Cell Carcinoma · Oncolytic Virus · TACE

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

West China hospital, Chengdu, Sichuan, China
Contact: Study coordinator (Tao Hai) · haitao42@hotmail.com · 028-85422654

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Trial of SHR-A2102 With Adebrelimab With or Without Other Anti-tumor Therapies in Recurrent/MetastaticHead and Neck Squamous Cell Carcinoma Cancer

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Chongqing, China · Chengdu, China

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Diffuse Astrocytoma, IDH-Mutant · Glioblastoma, IDH-wildtype · Brain Metastases, Adult

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beverly Hills, United States · Glendale, United States

PDT For Induction Therapy For Head And Neck Cancer

Squamous Cell Carcinoma · Head and Neck Cancer Squamous Cell Carcinoma · Head and Neck Cancer

Abroad (travel likely)RecruitingPHASE2

Boston, United States · Boston, United States

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Breast Cancer · Endometrial Cancer · Ovarian Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Orlando, United States · Boston, United States